March 25, 2024

Our Eurostars project “UTOPIA” has been granted

UTOPIA (Urinary Tract Infections Targeting O-linked glycosylated antigen Potency and Integrity Assays) aims to develop a vaccine against urinary tract infection with a novel bacterial glycoprotein. Spectralys will develop a pioneering ATR-FTIR based biosensor dedicated to glycoproteins.

Partners: GlyProVac (Odense, DK), Spectralys Biotech (Brussels, BE), LiteVax (Oss, NL) and Odense University Hospital (DK).

Duration: April 2024-March 2027